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Abstract
The aim of the study was to investigate the mode of action of (-)-α-pinene in terms of its modulation of
antibiotic resistance in Campylobacter jejuni. Broth microdilution and ethidium bromide accumulation assays
were used to evaluate the (-)-α-pinene antimicrobial activity, modulation of antimicrobial resistance, and
inhibition of antimicrobial efflux. The target antimicrobial efflux systems were identified using an insertion
mutagenesis approach, and C.jejuni adaptation to (-)-α-pinene was evaluated using DNA microarrays. Knock-
out mutants of the key up-regulated transcriptional regulators hspR and hrcA were constructed to investigate
their roles in C. jejuni adaptation to several stress factors, including osmolytes, and pH, using Biolog
phenotypical microarrays. Our data demonstrate that (-)-α-pinene efficiently modulates antibiotic resistance
in C. jejuni by decreasing the minimum inhibitory concentrations of ciprofloxacin, erythromycin and triclosan
by up to 512-fold. Furthermore, (-)-α-pinene promotes increased expression of cmeABC and another putative
antimicrobial efflux gene, Cj1687. The ethidium bromide accumulation was greater in the wild-type strain
than in the antimicrobial efflux mutant strains, which indicates that these antimicrobial efflux systems are a
target of action of (-)-α-pinene. Additionally, (-)-α-pinene decreases membrane integrity, which suggests that
enhanced microbial influx is a secondary mode of action of (-)-α-pinene. Transcriptomic analysis indicated
that (-)-α-pinene disrupts multiple metabolic pathways, and particularly those involved in heat-shock
responses. Thus, (-)-α-pinene has significant activity in the modulation of antibiotic resistance in C. jejuni,
which appears to be mediated by multiple mechanisms that include inhibition of microbial efflux, decreased
membrane integrity, and metabolic disruption. These data warrant further studies on (-)-α-pinene to develop
its use in the control of antibiotic resistance in Campylobacter.
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Abstract
The aim of the study was to investigate the mode of action of (-)-α-pinene in terms of its
modulation of antibiotic resistance in Campylobacter jejuni. Broth microdilution and ethid-
ium bromide accumulation assays were used to evaluate the (-)-α-pinene antimicrobial ac-
tivity, modulation of antimicrobial resistance, and inhibition of antimicrobial efflux. The target
antimicrobial efflux systems were identified using an insertion mutagenesis approach, and
C. jejuni adaptation to (-)-α-pinene was evaluated using DNA microarrays. Knock-out mu-
tants of the key up-regulated transcriptional regulators hspR and hrcA were constructed to
investigate their roles in C. jejuni adaptation to several stress factors, including osmolytes,
and pH, using Biolog phenotypical microarrays. Our data demonstrate that (-)-α-pinene effi-
ciently modulates antibiotic resistance in C. jejuni by decreasing the minimum inhibitory
concentrations of ciprofloxacin, erythromycin and triclosan by up to 512-fold. Furthermore,
(-)-α-pinene promotes increased expression of cmeABC and another putative antimicrobial
efflux gene, Cj1687. The ethidium bromide accumulation was greater in the wild-type strain
than in the antimicrobial efflux mutant strains, which indicates that these antimicrobial efflux
systems are a target of action of (-)-α-pinene. Additionally, (-)-α-pinene decreases mem-
brane integrity, which suggests that enhanced microbial influx is a secondary mode of ac-
tion of (-)-α-pinene. Transcriptomic analysis indicated that (-)-α-pinene disrupts multiple
metabolic pathways, and particularly those involved in heat-shock responses. Thus, (-)-α-
pinene has significant activity in the modulation of antibiotic resistance inC. jejuni, which ap-
pears to be mediated by multiple mechanisms that include inhibition of microbial efflux, de-
creased membrane integrity, and metabolic disruption. These data warrant further studies
on (-)-α-pinene to develop its use in the control of antibiotic resistance in Campylobacter.
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Introduction
The increasing incidence of bacterial pathogens that show antibiotic resistance has led to im-
paired efficacy of clinical treatments, prolonged illness and greater mortality. This rising anti-
microbial resistance has been accompanied by a decline in new antibiotic discovery over the
last few decades, which now poses a serious threat to public health. In Europe it has been esti-
mated that 25,000 patients die annually due to incurable infections with multidrug-resistant
(MDR) bacteria, and that the healthcare system is burdened with at least an additional 1.5 bil-
lion euros each year because of the prolonged treatments that are needed for infections with
MDR bacteria [1]. Campylobacter jejuni is the most prevalent bacterial cause of gastroenteritis,
and it shows high rates of ciprofloxacin resistance; as such, C. jejuni represents an important
part of this healthcare burden [2, 3]. Drug resistant Campylobacter are on the CDC list of seri-
ous threats in the U.S., which further indicates the importance of Campylobacter in public
health [4]. Campylobacter resistance to quinolone antibiotics is especially problematic, because
quinolone resistance has increased globally and tends to spread clonally [5].
One of the major mechanisms that contributes to the resistance of MDR bacteria is en-
hanced antimicrobial efflux, which extrudes antimicrobials of out of bacterial cells with broad
specificity. The most important antimicrobial efflux pump in C. jejuni is CmeABC, while Cme-
DEF and CmeG have secondary roles [6–8]. Alone or in combination with specific point muta-
tions and antibiotic resistance genes, these antimicrobial efflux pumps provide increased
resistance to clinically important classes of antibiotics.
To restore the activity of antibiotics that are already available on the market, research has
been devoted to finding new compounds with activities that can be used to inhibit antimicrobial
efflux in bacteria [9–12]. However, to date, no inhibitors of these antimicrobial efflux pumps
have been licensed for clinical use, although some drugs, such as the calcium ion influx inhibitor
verapamil that is licensed for arrhythmia treatment, also show inhibitory activity against antimi-
crobial efflux. Also, some new natural products have recently been identified for potential use as
antimicrobial efflux pump inhibitors, based on findings from in-vitro studies [13–17].
One of these natural compounds that has been shown to have antimicrobial activity against
various microorganisms is the monoterpene α-pinene, which is naturally present in various es-
sential oils [18]. α-Pinene is also one of the constituents of an essential oil from Alpinia katsu-
madai seeds (J. Kovač, unpublished data), which we have shown to have modulatory activity
towards antimicrobial resistance in C. jejuni and Staphylococcus aureus [10, 13]. α-Pinene ex-
ists naturally as both (+)-α-pinene and (-)-α-pinene [11]. (-)-α-Pinene was investigated here,
in terms of its activity as an antimicrobial, its modulation of antimicrobial resistance, and its in-
hibition of antimicrobial efflux, using antibiotic-susceptible and antibiotic-resistant C. jejuni
isolates from different sources. Furthermore, the C. jejuni responses to treatment with (-)-α-pi-
nene were studied using transcriptomic and phenotypic microarray approaches.
Materials and Methods
Chemicals
Erythromycin, ciprofloxacin, ethidium bromide (EtBr), carbonyl cyanide-m-chlorophenylhy-
drazone (CCCP), reserpine, (-)-α-pinene, resazurin sodium salt, and menadion were from
Sigma-Aldrich Chemie (Steinheim, Germany), triclosan and chloramphenicol were from Cal-
biochem (Merck KGaA, Darmstadt, Germany), ampicillin was from Roche Diagnostics
(Mannheim, Germany), and kanamycin was fromMerck (Darmstadt, Germany).
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Bacterial strains and growth conditions
Frozen stocks (from -80°C storage) of the C. jejuni strains listed in S1 Table were cultured on se-
lective Karmali agar and Mueller-Hinton agar (Oxoid, Hampshire, UK), or in Mueller-Hinton
broth (Oxoid), and incubated at 42°C under microaerobic conditions (5% O2, 10% CO2, in N2).
Escherichia coli were cultured on Luria-Bertani agar (Oxoid) at 37°C. When needed, the Muel-
ler-Hinton agar was supplemented with kanamycin (30 mg/L) or chloramphenicol (4 mg/L),
and the Luria-Bertani agar was supplemented with ampicillin (50 mg/L).
Antimicrobial and resistance-modulation assays
The antimicrobial activity of (-)-α-pinene was determined on 17 C. jejuni strains and two C.
jejunimutants with knocked-out antimicrobial efflux genes (ΔcmeB and ΔCj1687), using the
broth microdilution method. Briefly, the tested compounds were dissolved in dimethylsulph-
oxide (final concentration, 2.5%) and serially diluted in Mueller-Hinton broth in black microti-
tre plates, and the C. jejuni cultures were added at a concentration of 5 ×105 CFU/mL, to the
final volume of 0.1 mL/well. After 24 h incubation at 42°C under microaerobic conditions,
10 μL resazurin reagent was added to each well, which consisted of 10 mM tetrazolium salts
and 0.8 mMmenadion. Following a 2-h incubation at 42°C, the fluorescence intensity was
measured at 550 nm and 959 nm, using a microplate reader (Tecan, Mannedorf/Zurich, Swit-
zerland) [19]. The minimum inhibitory concentrations (MICs) were defined as the minimal
concentrations at which the fluorescence signal declined to the level of the blank. Modulation
of antimicrobial resistance was evaluated using the same method, for nine C. jejuni strains and
two knocked-out antimicrobial efflux mutants (ΔcmeB and ΔCj1687), except that the medium
was supplemented with subinhibitory concentrations of (-)-α-pinene (62.5 mg/L or 125 mg/L)
for the determination of the MICs of ciprofloxacin, erythromycin, triclosan, and ethidium bro-
mide. The (-)-α-pinene modulation factors were defined as the ratios of the MICs for the anti-
microbial alone and for the antimicrobial in the presence of (-)-α-pinene. A modulation factor
>2 was set as the cut-off for biologically significant resistance modulation [14].
Membrane integrity
The influence of 62.5 mg/L and 125 mg/L (-)-α-pinene on membrane integrity of C. jejuni
NCTC 11168 was followed using LIVE/DEAD BacLight Bacterial Viability kits (L-7012; Mo-
lecular Probes, Eugene, Oregon, USA) [20]. A mixture of the green fluorescent dye SYTO 9
and propidium iodide was prepared and used according to the manufacturer instructions (Mo-
lecular Probes). This dye mixture was added to 100 μL C. jejuni cultures (OD600, 0.2; 1:1, v/v)
that were untreated or treated with (-)-α-pinene. The kinetics of propidium iodide intracellular
penetration were followed by measuring the relative fluorescence units (RFUs) in 60-s intervals
over 1 h, in terms of the SYTO 9 fluorescence at 481 nm and 510 nm in a microplate reader
(Tecan). Two independent experiments were carried out in triplicate in black microtitre plates.
The membrane disruption (%) was calculated from the kinetics measurements of the treated
relative to the untreated cultures over the last 10 min of the assay.
Ethidium bromide accumulation
The influence of 62.5 mg/L and 125 mg/L (-)-α-pinene on EtBr accumulation in C. jejuniNCTC
11168, ΔcmeB and ΔCj1687 was determined. Further screening was carried out with 62.5 mg/L
(-)-α-pinene on 16 C. jejuni isolates (S1 Table), as previously described [13]. Briefly, exponential
phase cultures were washed and resuspended in phosphate-buffered saline (OD600, 0.2). After a
10-min incubation at 37°C, the efflux pump inhibitors were added to 100 μL cultures in black
Antibiotic Resistance Modulation in Campylobacter jejuni
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microtitre plates, and incubated for 10 min at 37°C before adding EtBr to a final the concentra-
tion of 0.5 mg/L. The kinetics of intracellular EtBr accumulation were measured at 500 nm and
608 nm using a Tecan microplate reader, at 45-s intervals for 1 h. In parallel to the (-)-α-pinene
treatments, the reference efflux pump inhibitors CCCP (10 mg/L) and reserpine (100 mg/L)
were tested. The selected concentrations of the efflux pump inhibitors had no inhibitory effects
on bacterial growth. Other EPIs, such as verapamil, NMP, and PaβN were also tested in the pre-
liminary experiments, but they were excluded from further studies due to their low activity (data
not shown). Measurements were carried out in triplicate and the means of the last 10 measure-
ments were used in the statistical analysis.
Transcriptional response to (-)-α-pinene
The influence of (-)-α-pinene on gene expression in C. jejuni NCTC 11168 was determined
using DNA microarrays and qRT-PCR. Exponential phase cultures were adjusted to OD600 0.2
in Mueller-Hinton broth. Five millilitres of culture were treated with 62.5 mg/L (-)-α-pinene
dissolved in dimethylsulphoxide. Only dimethylsulphoxide (0.048%) was added to the untreat-
ed samples. The cultures were incubated for 2 h, microaerobically and with shaking (160 rpm),
at 42°C. Experiments were carried out as four biological replicates. RNA Protect Bacteria re-
agent (Qiagen, Maryland, USA) was added to the cultures, and the total RNA was isolated
using RNeasy mini kits (Qiagen), and treated with Ambion Turbo DNA-free kits (Invitrogen,
USA).
Microarrays with 4,751 probes that targeted 1,756 genes that are specific to C. jejuni NCTC
11168 (Mycroarray, Biodiscovery-LLC, MI, USA) were used for the gene-expression analysis,
as described previously [21]. The cDNA was synthesised with random hexamers, SuperScript
III Reverse Transcriptase, and aminoallyl dUTP (all supplied by Invitrogen, USA) and labelled
with a monofunctional NHS-ester dye, as Cy3 or Cy5 (GE Healthcare, Buckinghamshire, UK).
The DNA concentration and the labelling efficiency were determined spectrophotometrically
(NanoDrop 1000; Thermo Scientific, Waltham, MA, USA). Four biological replicates were
hybridised to four microarrays, according to the manufacturer protocol, and incubated for 24
h at 42°C, and scanned at 550 nm for Cy3 and 650 nm for Cy 5, using a microarray scanner
(GenePix 4100A; Molecular Devices, Sunnyvale, CA, USA), to 5 μm resolution. The fluores-
cence intensities were converted to digital signals using the GenepixPro 7.0 programme (Mole-
cularDevices, Sunnyvale, CA, USA). The microarray data was deposited with the NCBI Gene
Expression Omnibus, under the accession number GSE59879, GPL19011.
The expression of four genes was confirmed by quantitative real-time PCR using a real-time
PCR detection system (ABI 7500; Applied Biosystems, Thermo Scientific, Waltham, MA, USA)
with Universal KAPA SYBR One-Step qRT-PCR kits (Kapa Biosystems, Boston, USA) and the
same RNA template as in the microarray experiments. Quantitative RT-PCR primers (Supple-
mentary Information S2 Table) were designed using the online tool Primer3 (http://frodo.wi.
mit.edu/). Standard quantification curves were generated for each of the RNA templates, using
10-fold dilution series between 25 ng/μL and 0.0025 ng/μL. Quantitation was performed in
15 μL reactions with three technical replicates of three biological replicates, according to the fol-
lowing programme: 10 min at 50°C, 5 min at 60°C, 3 min at 95°C and 40 cycles of 10 s at 95°C
and 30 s at 58°C, including the melt curve analysis performed after amplification. Here, 16S
rRNA was used for the internal normalisation standard for the calculation of the relative fold-
change in gene expression, by the comparative threshold cycle method (ΔΔCt) [22].
Antibiotic Resistance Modulation in Campylobacter jejuni
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Construction of insertional mutants
Three C. jejuni NCTC 11168 knock-out mutants with disrupted open reading frames of the
hspR, hrcA and Cj1687 genes were constructed (S2 Table) using an insertion mutagenesis ap-
proach. The internal fragments of the genes were replaced with the kanamycin resistance cas-
sette aphA-3 (Fig 1). The PCR products used for construction of these mutants were amplified
with GoTaq polymerase (Promega Corporation, Madison, WI, USA) using the primers listed
in S2 Table. Following amplification, these were purified using a Wizard SV gel and PCR
clean-up system (Promega), and digested with HindIII or PstI (Thermo Scientific, Waltham,
MA, USA), or both. The restricted PCR products were incubated at 80°C, to deactivate the re-
striction enzymes, ligated using Quick ligation kits (New England Biolabs, Ipswich, MA, USA),
and cloned into pGEM-T Easy Vectors using T4 DNA ligase (Promega). The plasmid was am-
plified in competent E. coli DH5α, isolated using GenElute Plasmid Miniprep kits (Sigma,
St. Luis, MO, USA), and transformed into C. jejuni NCTC 11168 by natural transformation.
The transformants with the insert were selected on Mueller-Hinton agar supplemented with
kanamycin (30 mg/L), and confirmed with PCR (S2 Table).
Metabolic response to inactivated genes
C. jejuni NCTC 11168 and the ΔhspR and ΔhrcAmutants were prepared in IF-0a inoculating
fluid (Biolog, Hayward, CA, USA), mixed with redox indicator Dye D, according to the
Fig 1. Scheme of the insertional mutagenesis strategies (not to scale). Box arrows, target open reading frames; solid arrows, primers used for DNA
fragment amplification (from left to right: F1-F, F1-R, F2-F, F2-R, specific for each individual mutant, as listed in S2 Table); blue dots, target gene; blue
rectangles, deleted regions substituted with a kanamycin cassette (kan).
doi:10.1371/journal.pone.0122871.g001
Antibiotic Resistance Modulation in Campylobacter jejuni
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manufacturer instructions, and dispensed (100 μL/well) using carbon utilisation, osmolality,
and pH phenotypic plates PM1, PM2A, PM9 and PM10 (Biolog). The PM plates were placed
in plastic bags together with microaerophilic atmosphere generating sachets (Oxoid), sealed
and fixated in the automatic plate reader (Omnilog; Biolog) trays using adhesive tape. Plates
were incubated in automatic plate reader at 42°C and the metabolism of different carbon
sources, growth on different osmolytes and at different pHs was followed spectrophotometri-
cally every 15 min for 48 h. The endpoint values were used in the comparative statistical
analysis.
Statistical analysis
The statistical significances of the data for the antimicrobial actions, modulation of antimicro-
bial resistance, and EtBr accumulation were determined using one-way ANOVA with appro-
priate post-hoc tests, using the SPSS software, version 21 (IBM Corp., Armonk, NY, USA).
Analysis of the Biolog phenotypic microarray data was carried out using MS Excel and Stu-
dent’s t-tests, and analysis of the DNAmicroarray data was performed with the R software
using the LIMMA package, as previously described [21, 23]. Statistical significance was set at
p<0.05, and the cut-off for significance of the relative fold-changes in the modulation of anti-
microbial resistance set at>2, the gene expression between untreated and treated cultures set
at2, and in the growth on phenotypic plates set at1.5.
Results
Antimicrobial activity and modulation of antimicrobial resistance of (-)-α-
pinene
The antimicrobial activity of (-)-α-pinene was determined on 16 strains of C. jejuni (S1 Table).
The MICs of (-)-α-pinene were 1000 mg/L or higher in all of the tested strains, including those
tested in the antimicrobial-resistance-modulation assay (Table 1). These high MICs confirmed
the insignificant antimicrobial activity of (-)-α-pinene. As a potential modulator of antimicro-
bial resistance, (-)-α-pinene was tested at 62.5 mg/L and 125 mg/L in combination with the
antibiotics ciprofloxacin and erythromycin, the disinfectant triclosan, and the antimicrobial ef-
flux pump substrate EtBr, on the C. jejuni NCTC 11168 reference strain. At 62.5 mg/L, (-)-α-
pinene decreased the MICs of these antimicrobials by up to 2-fold. However, at 125 mg/L,
(-)-α-pinene reduced the MICs of the various antimicrobials from 32-fold to over 512-fold
(Table 1).
Due to the significantly stronger modulation of antimicrobial resistance of (-)-α-pinene at
125 mg/L, this higher concentration was further tested on eight other C. jejuni isolates and two
mutants with inactivated antimicrobial efflux genes, ΔcmeB and ΔCj1687 (Table 1). These data
indicated pronounced modulation of antimicrobial resistance by (-)-α-pinene with all of these
strains for most of the antimicrobials tested. Significant MIC reductions were produced also in
the ΔcmeB and ΔCj1687mutants derived from the wild type NCTC 11168, which suggest that
this modulatory activity of 125 mg/L (-)-α-pinene is not dependent on its inhibition of antimi-
crobial efflux.
Influence of (-)-α-pinene on membrane integrity
As for the modulation of antimicrobial resistance, both 62.5 mg/L and 125 mg/L (-)-α-pinene
were tested for their influence on membrane integrity in C. jejuni, to determine whether mem-
brane permeability is the main mechanism of its modulation of antimicrobial resistance. The
membrane integrity of cultures treated with 62.5 mg/L (-)-α-pinene was 20% higher than that
Antibiotic Resistance Modulation in Campylobacter jejuni
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of the untreated cultures after 1-h treatment, while at 125 mg/L (-)-α-pinene, the membrane
integrity was decreased by 39% (Fig 2). Hence, at this higher concentration of 125 mg/L (-)-α-
pinene, the consequent disruption of the membranes is likely to have contributed to its modu-
lation of antimicrobial resistance. Cultures incubated at 80°C for 15 min were used as a positive
control for disrupted membranes, and these showed 64% decreased membrane integrity, com-
pared to the untreated control cultures. These differences were calculated based on the kinetics
measurements over the last 10 min of the 1-h assays, and they were statistically significant
(p<0.0001). The disruptive impact of (-)-α-pinene on membrane integrity is not surprising,
as it is known that monoterpenes can cause alterations in membrane permeability [24].
Inhibition of antimicrobial efflux by (-)-α-pinene
Again, both 62.5 mg/L and 125 mg/L (-)-α-pinene were tested for their impact on intracellular
EtBr accumulation in C. jejuni NCTC 11168 and the two mutants (ΔcmeB and ΔCj1687). Com-
pared to the non-treated control, both of these concentrations of (-)-α-pinene increased the
EtBr accumulation; however, 62.5 mg/L (-)-α-pinene resulted in greater EtBr accumulation
(Fig 3). As 62.5 mg/L (-)-α-pinene did not have a negative impact on membrane integrity, this
was used in the further screening on a larger set of 16 isolates (S1 Table). This enabled the in-
vestigation of only the inhibitory effects of (-)-α-pinene on antimicrobial efflux. Here, there
was increased EtBr accumulation in all of these 16 tested strains when 62.5 mg/L (-)-α-pinene
was added (Fig 4). This (-)-α-pinene concentration increased the EtBr accumulation signifi-
cantly more than seen for CCCP and reserpine in all of these tested strains, which confirms its
inhibitory activity against antimicrobial efflux. Here it is important to note that (-)-α-pinene
was tested at a lower concentration (62.5 mg/L) than reserpine (100 mg/L), and at a higher con-
centration than CCCP (10 mg/L), to avoid the toxic effects of CCCP.
To identify the target efflux system of (-)-α-pinene, EtBr accumulation in the two mutants
in the antimicrobial efflux genes was investigated. In comparison with the control wild-type C.
Table 1. Antimicrobial activity andmodulation of antimicrobial resistance of (-)-α-pinene for the different strains ofCampylobacter jejuni.
C. jejuni MIC (mg/L)
strain AP CIP ERY TC EtBr
-AP +AP MF -AP +AP MF -AP +AP MF -AP +AP MF
NCTC 11168* 1000 0.063 0.031 2 0.5 0.25 2 8 4 2 1 1 1
NCTC 11168 1000 0.063 <0.002 >32 0.5 <0.002 >256 8 <0.125 >64 1 <0.008 >128
K49/4 2000 0.063 0.002 32 0.25 <0.002 >128 4 0.25 16 2 0.016 128
53124 1000 4 2 2 0.25 0,063 4 4 4 1 0.5 0.5 1
375/06 2000 4 1 4 0.125 <0.008 >16 4 <0.125 >32 0.25 <0.008 >32
57360 1000 4 <0.008 >512 0.25 <0.002 >128 8 <0.063 >128 0.25 <0.008 >32
58429 1000 4 <0.031 >128 0.25 <0.125 >2 4 <0.125 >32 0.25 <0.063 >4
60089 >2000 8 2 4 0.125 0.063 2 32 32 1 8 8 1
1518/08 2000 8 <0.031 >256 0.125 <0.002 >64 16 <0.031 >512 0.5 <0.008 >64
573/03 2000 16 4 4 0.125 0.063 2 16 <0.063 >256 0.5 <0.008 >64
ΔcmeB 1000 0.016 <0.001 >16 0.063 <0.002 >32 8 <0.063 >128 0.063 <0.008 >8
ΔCj1687 2000 0.063 <0.001 >63 0.125 <0.002 >64 8 <0.063 >128 0.5 <0.008 >64
MIC, minimal inhibitory concentration; AP, (-)-α-pinene; CIP, ciproﬂoxacin; ERY: erythromycin; TC, triclosan; EtBr, ethidium bromide;-AP, in the absence
of (-)-α-pinene; +AP, with 125 mg/L (-)-α-pinene, MF, modulation factor.
* In this case +AP was applied in concentration 62.5 mg/L.
doi:10.1371/journal.pone.0122871.t001
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Fig 2. Influence of (-)-α-pinene onmembrane integrity ofC. jejuniNCTC 11168.Membrane integrity of wild-typeC. jejuni NCTC 11168 cultures,
untreated culture, culture treated with 125 mg/L (-)-α-pinene or 62.5 mg/L (-)-α-pinene, heat treated culture and blank.
doi:10.1371/journal.pone.0122871.g002
Fig 3. Influence of (-)-α-pinene, CCCP and reserpine on ethidium bromide accumulation. (A) Reference strainC. jejuni NCTC 11168, (B) C. jejuni
NCTC 11168 ΔcmeB knock-out mutant, (C) C. jejuniNCTC 11168 ΔCj1687 knock-out mutant.
doi:10.1371/journal.pone.0122871.g003
Antibiotic Resistance Modulation in Campylobacter jejuni
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jejuni NCTC 11168, the increase in EtBr accumulation with 62.5 mg/L (-)-α-pinene was signif-
icantly lower in the ΔcmeB and ΔCj1687mutants (Fig 3), although this remained above the
EtBr accumulation in the wild-type. This finding suggests that (-)-α-pinene inhibits both of
these antimicrobial efflux systems.
Transcriptional response to (-)-α-pinene
After a 2-h treatment with 62.5 mg/L (-)-α-pinene, 128 genes of C. jejuni NCTC 11168 were
differentially expressed (with the cut-off set at2-fold difference; Table 2 and S3 Table). Of
those, 108 were up-regulated, and 20 were down-regulated. The Clusters of Orthologous
Groups functional classification of these differentially expressed genes revealed that the up-reg-
ulated genes were mainly involved in amino-acid transport and metabolism (12 genes), transla-
tion (12 genes), inorganic ion transport and metabolism (8 genes), posttranslational
modification and chaperones (8 genes), and unknown functions (36 genes, which included
‘poorly characterised’, ‘function unknown’, ‘general function prediction only’). The down-reg-
ulated genes were scattered into 12 of the functional categories (Table 2). Interestingly, howev-
er, the most strongly up-regulated genes (>10-fold) fell into the groups of posttranslational
modification and chaperones, and transcription, which included the chaperone-encoding
genes grpE, dnaK, and clpB, and the heat-shock regulator hrcA. In these two functional
Fig 4. Influence of (-)-α-pinene on EtBr accumulation in the 16C. jejuni strains.Relationship between EtBr accumulation in untreated cultures and in
cultures treated with 62.5 mg/L (-)-α-pinene. Each symbol represents a single isolate. Solid squares, antibiotic resistant strains (resistant to three or more
unrelated antibiotics); open circles, antibiotic sensitive strains.
doi:10.1371/journal.pone.0122871.g004
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categories, another two heat-shock-response genes that encode the chaperones groES and cbpA
and the transcriptional repressor hspR were also up-regulated, although to lower levels (2-fold
to 4-fold). As well as these heat-shock-response genes, the antimicrobial efflux pump genes
cmeABC were up-regulated by 2.7-fold to 2.2-fold, respectively. Another, as yet uncharacterised
gene that encodes a putative antimicrobial efflux protein, Cj1687, was 2.5-fold up-regulated
after the treatment with (-)-α-pinene. The omp50 gene that was previously identified as an
outer membrane protein and a phosphotyrosine kinase [25] was 4.9-fold up-regulated here.
Several ribosomal genes (rps, rpl) and genes involved in purine biosynthesis (purM, apt, purD),
glutamate metabolism (murI,metE,metF, glnA, gltBD), and iron–sulphur homeostasis
(chuAD, tonB3, tonB2) were expressed at higher levels (2.1-fold to 8.1-fold up-regulated) after
the treatment with (-)-α-pinene. On the other hand, aspartate-ammonia lyase (aspA) was the
most strongly down-regulated (4.6-fold) metabolic gene, together with the genes that encode
succinate dehydrogenase (sdhA, sdhC), fumarate hydratase (fumC), and anaerobic C4-dicar-
boxylate antiporter dcuA, which were up to 3.2-fold down-regulated following the treatment
with (-)-α-pinene.
Metabolic response to inactivated genes
The hspR, hrcAmutants and wild-type C. jejuni NCTC 11168 were grown on Biolog phenotype
MicroArrays with different carbon sources and in presence of different osmolytes and pH, to
investigate their roles in adaptation to these stresses. The growth of the mutants was compared
to the growth of the wild-type strain (S4 Table). The hspRmutant grew better on some of the
osmolytes, such as 6% NaCl with KCl, sodium sulphate, sodium formate, sodium lactate, and
sodium phosphate, while growth of the hrcAmutant, on the other hand, was inhibited by these
and several of the other osmolytes. The hrcAmutant did not use a wide range of the carbon
sources as efficiently as the wild-type.
Table 2. Functional categories of the differentially expressed genes in Campylobacter jejuni.
Clusters of orthologous groups category Up-regulated genes Down-regulated gens Differentially expressed genes
Energy production and conversion 2 3 5
Amino acid transport and metabolism 12 1 13
Nucleotide transport and metabolism 5 0 5
Carbohydrate transport and metabolism 1 2 3
Coenzyme transport and metabolism 4 1 5
Lipid transport and metabolism 2 0 2
Translation 12 0 12
Transcription 3 2 5
Replication, recombination and repair 5 0 5
Cell wall/ membrane biogenesis 5 2 7
Cell motility 1 0 1
Posttranslational modiﬁcation, chaperones 8 3 11
Inorganic ion transport and metabolism 8 1 9
General function prediction only 9 2 11
Function unknown 1 1 2
Signal transduction mechanisms 1 1 2
Defense mechanisms 3 1 4
Poorly characterized 26 0 26
Total 108 20 128
doi:10.1371/journal.pone.0122871.t002
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Discussion
(-)-α-pinene has negligible anti-Campylobacter activity, with MICs of 1000 mg/L or higher
against all of the tested strains. Unlike (+)-α-pinene, this (-)-α-pinene enantiomer was also
previously reported to have no inhibitory effects in fungi and with S. aureus [11]. Although
(-)-α-pinene did not inactivate C. jejuni growth, it showed remarkable modulatory activity of
antimicrobial resistance when applied in combination with ciprofloxacin, erythromycin, triclo-
san and ethidium bromide. We observed concentration-dependent activity of (-)-α-pinene
here, and investigated the mechanisms of its action at 62.5 mg/L and 125 mg/L. Although the
modulation of antimicrobial resistance was substantially more pronounced at 125 mg/L (-)-α-
pinene, the EtBr accumulation remained at similarly high levels.
These data suggest the involvement of at least two different modes of action. Indeed, investi-
gation of the membrane integrity revealed increased membrane permeability with 125 mg/L
(-)-α-pinene. At this concentration of (-)-α-pinene, the synergistic effects of increased mem-
brane permeability and intracellular accumulation due to the inhibition of antimicrobial efflux
provided the best modulation of antimicrobial resistance.
Previous reports have demonstrated the modulation of antimicrobial resistance and efflux
of the diarylheptanoid and flavonoid constituents of A. katsumadai seeds inMycobacterium
smegmatis at comparable concentrations, although its terpene compounds were studied only as
a mixture, with the essential oil at significantly higher concentrations [13, 14]. Inhibition of an-
timicrobial efflux was also previously achieved inM. smegmatis and S. aureus, with paradol-re-
lated and gingerol-related compounds isolated from Aframomum melegueta, and with a novel
antibacterial natural product that was isolated fromHypericum olympicum L. cf. uniflorum, re-
spectively [15, 17].
To determine the antimicrobial efflux system that (-)-α-pinene targets, we carried out com-
parative accumulation assays in the wild-type and with the mutant strains with inactivated an-
timicrobial efflux genes, ΔcmeB and Δcj1687. In the presence of (-)-α-pinene, the decrease in
EtBr accumulation almost to the level of the untreated culture in ΔcmeB and ΔCj1687 suggests
that these two efflux proteins are the likely the targets of (-)-α-pinene.
To date, (-)-α-pinene is the first plant-derived compound that shown inhibition of antimi-
crobial efflux in Campylobacter to be described and characterized. Cytotoxicity of α-pinene
was previously investigated with the HeLa and Cos7 cell lines, where IC50 values of 357.9 mg/L
and 337.5 mg/L were reported, respectively [26]. As these IC50 values for α-pinene are more
than 2-fold greater than those used in the present modulation assays, and more than 5-fold
greater than those used in the present EtBr accumulation assays, (-)-α-pinene has the potential
to be further investigated as a means for the control of antibiotic resistant C. jejuni.
To explore the C. jejuni responses to (-)-α-pinene, we analysed the changes in the C. jejuni
transcriptome before and after the 2-h (-)-α-pinene treatment. Here, we observed increases in
the expression of the cmeABC and Cj1687 antimicrobial efflux genes that were identified as po-
tential targets for antimicrobial efflux inhibition, which confirms the increased need for
CmeABC and Cj1687 activity after inhibition by (-)-α-pinene. The involvement of (-)-α-pi-
nene in alterations to membrane permeability, as a complementary mechanism of its action,
was also indicated by the increased expression of the outer membrane protein product of the
omp50 gene. This protein was previously shown to modulate phosphorylation of proteins in-
volved in capsule production [25]. Up-regulation of omp50 appears to be a strategy for bacterial
adaptation, as opm50 is likely to enhance the production of surface polysaccharides, and there-
by to contribute to decreased membrane permeability and decreased antimicrobial influx [25].
Similar responses of C. jejuni were also observed previously after exposure to erythromycin,
which like (-)-α-pinene, is a hydrophobic compound [27]. Furthermore, treatment of C. jejuni
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with (-)-α-pinene evoked increased expression of ribosomal and purine biosynthesis genes,
which indicated that there were metabolic changes, and thereby the associated need for in-
creased protein synthesis. Previous reports have indicated similar transcriptional changes in C.
jejuni in response to stomach acid, which evoked up-regulation of purB [28]. The product of
the up-regulated glutamate synthetase gene (gltBD) catalyses the condensation of glutamate,
which is involved in osmoadaptation and can be further converted to aspartate. Then, as well
as coding for heat-shock proteins, up-regulation of the gltD and glnA genes was previously re-
ported in C. jejuni in response to salt stress [29]. Aspartate-ammonia lyase (aspA), which is the
most strongly down-regulated gene associated with energy metabolism, cleaves carbon–nitro-
gen bonds and catalyses the conversion of L-aspartate into fumarate and ammonia. Additional-
ly, down-regulation of succinate dehydrogenase genes (sdhA, sdh) contributes to inhibition of
fumarate biosynthesis, obstruction of oxidative energy metabolism, and conversion of fumarate
to malate by fumarate hydratase (fumC). Metabolic changes and an imbalance in Krebs cycle
intermediates were also reflected in the down-regulation of fumC and the anaerobic C4-dicar-
boxylate antiporter gene dcuA. Up-regulation of iron–sulphur homeostasis genes, such as
chuAD, tonB3 and tonB2, suggested an increase in the transport of the metal ions and sidero-
phores that are involved in respiration and DNA synthesis.
The changes in gene expression caused by (-)-α-pinene are strikingly similar to those that
have previously been observed in a mutant with a defective transcriptional regulator hspR,
which showed highly up-regulated heat-shock-related genes: grpE, dnaK, clpB and hrcA [30].
Similar responses were also observed after treatment with the natural antimicrobial compound
benzyl isothiocyanate, which promotes protein aggregation [31]. The simple heat-shock-re-
sponse model from a study by Holmes et al. (2010) suggested repression of groES and groEL by
hrcA, and repression of dnaK, cbpA and the clpB operon by hspR, which become derepressed in
the event of heat shock, allowing the expression of hrcA [30]. HrcA, however, needs the assis-
tance of groES and groEL for posttranscriptional modifications that enable its activity [30].
Characterisation of mutant strains using phenotypic microarrays revealed increased adapta-
tion of ΔhspR to increased concentrations of several sodium salts. On the other hand, the
growth of the mutant ΔhrcA was attenuated in the presence of a wide variety of osmolytes and
high pH. The ΔhrcAmutant also did not use a wide range of carbon sources, compared to the
wild-type. These data demonstrate that the heat-shock transcriptional regulators are also im-
portant for efficient responses to stresses other than high temperatures.
In conclusion, (-)-α-pinene is here confirmed as an efficient modulator of antimicrobial re-
sistance in C. jejuni, with at least two different mechanisms that contribute synergistically to
this activity. Lower concentrations of (-)-α-pinene show pronounced inhibition of antimicrobi-
al efflux through the targeting of the main efflux system CmeABC and another, as yet unchar-
acterised, efflux protein, Cj1687. The higher concentration of (-)-α-pinene additionally
targeted the membrane, with increased permeability, thereby promoting the influx of antimi-
crobials. The low antimicrobial activity that we observed appears to be derived from the effec-
tive bacterial adaptation to (-)-α-pinene treatment provided by the heat-shock response, and
efficient changes in protein synthesis and energy metabolism. Due to the promising modula-
tion of antimicrobial resistance and its previously reported low cytotoxicity, (-)-α-pinene has
the potential to be further investigated for the control of antimicrobial resistant in C. jejuni.
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